Controlled Clinical Trial of Selective Decontamination for the Treatment of Severe Acute Pancreatitis
Open Access
- 1 July 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 222 (1), 57-65
- https://doi.org/10.1097/00000658-199507000-00010
Abstract
A randomized, controlled, multicenter trial was undertaken in 102 patients with objective evidence of severe acute pancreatitis to evaluate whether selective decontamination reduces mortality. Secondary pancreatic infection is the major cause of death in patients with acute necrotizing pancreatitis. Controlled clinical trials to study the effect of selective decontamination in such patients are not available. Between April 22, 1990 and April 19, 1993, 102 patients with severe acute pancreatitis were admitted to 16 participating hospitals. Patients were entered into the study if severe acute pancreatitis was indicated, on admission, by multiple laboratory criteria (Imrie score > or = 3) and/or computed tomography criteria (Balthazar grade D or E). Patients were randomly assigned to receive standard treatment (control group) or standard treatment plus selective decontamination (norfloxacin, colistin, amphotericin; selective decontamination group). All patients received full supportive treatment, and surveillance cultures were taken in both groups. Fifty patients were assigned to the selective decontamination group and 52 were assigned to the control group. There were 18 deaths in the control group (35%), compared with 11 deaths (22%) in the selective decontamination group (adjusted for Imrie score and Balthazar grade: p = 0.048). This difference was mainly caused by a reduction of late mortality (> 2 weeks) due to significant reduction of gram-negative pancreatic infection (p = 0.003). The average number of laparotomies per patient was reduced in patients treated with selective decontamination (p < 0.05). Failure of selective decontamination to prevent secondary gram-negative pancreatic infection with subsequent death was seen in only three patients (6%) and transient gram-negative pancreatic infection was seen in one (2%). In both groups of patients, all gram-negative aerobic pancreatic infection was preceded by colonization of the digestive tract by the same bacteria. Reduction of gram-negative colonization of the digestive tract, preventing subsequent pancreatic infection by means of selective decontamination, significantly reduces morbidity and mortality in patients with severe acute necrotizing pancreatitis.Keywords
This publication has 48 references indexed in Scilit:
- Decreased mortality rate and length of hospital stay in surgical intensive care unit patients with successful selective decontamination of the gutCritical Care Medicine, 1993
- Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tractIntensive Care Medicine, 1992
- Surgical strategies in the treatment of pancreatic necrosis and infectionBritish Journal of Surgery, 1991
- APACHE-II SCORE FOR ASSESSMENT AND MONITORING OF ACUTE PANCREATITISThe Lancet, 1989
- Controlled Open Lesser Sac Drainage for Pancreatic AbscessAnnals of Surgery, 1986
- lmproved Survival in 45 Patients with Pancreatic AbscessAnnals of Surgery, 1985
- Computed Tomography and the Prediction of Pancreatic Abscess in Acute PancreatitisAnnals of Surgery, 1985
- Prognostic factors in acute pancreatitis.Gut, 1984
- Pancreatic Resection versus Peritoneal Lavation for Acute Fulminant PancreatitisAnnals of Surgery, 1984
- The Timing of Biliary Surgery in Acute PancreatitisAnnals of Surgery, 1979